GALT

gene product
Galactose-1-phosphate uridyl transferase (GALT) catalyzes the second step of the Leloir pathway of galactose metabolism, namely the conversion of UDP-glucose + galactose-1-phosphate to glucose-1-phosphate + UDP-galactose. The absence of this enzyme results in classic galactosemia in humans and can be fatal in the newborn period if lactose is not removed from the diet. The pathophysiology of galactosemia has not been clearly defined. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]
More gene data

Featured antibodies

Antibodies

 

Filters

Antibodypedia Validation Initiative

Validation method

Application

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

  or   Clear
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
Validated within AVI
Eligible for validation within AVI
246 antibodies from 28 providers.

Antibody properties

Applications

or Cancel
AntibodyRefsTypeAVIWBELICCIPIHCFC
antibodies-online
64 antibodies
Biorbyt
10 antibodies
Aviva Systems Biology
2 antibodies
Proteintech Group
1 antibody
Novus Biologicals
7 antibodies
Abnova Corporation
6 antibodies
NovoPro Bioscience Inc.
4 antibodies
LifeSpan BioSciences, Inc.
52 antibodies
Abgent
3 antibodies
OriGene
4 antibodies
Atlas Antibodies
2 antibodies
Acris Antibodies GmbH
5 antibodies
Invitrogen Antibodies
5 antibodies
ProSci
3 antibodies
GeneTex
2 antibodies
Bioworld Technology, Inc
1 antibody
Boster Biological Technology
2 antibodies
St John's Laboratory
1 antibody
RabMAbs
2 antibodies
NSJ Bioreagents
1 antibody
Creative Biolabs
4 antibodies
Creative Diagnostics
4 antibodies
RayBiotech, Inc.
1 antibody
United States Biological
37 antibodies
MyBioSource
4 antibodies
Sigma-Aldrich
4 antibodies
Abbexa
3 antibodies